Navigation Links
Probiotic Cleanser Creator Probiotic Action Offers New Treatment Options for Rosacea

Miami, FL (PRWEB) August 30, 2013

Earlier this week, released news surrounding the new FDA approved topical ointment for the reduction of redness associated with rosacea. While the article states that the topical treatment is meant to only reduce the reddening of skin, the approval of this product is the first to ever be proven to reduce rosacea associated redness. Although the product is said to reduce redness, the product will not guard against the pimples and bumps associated with the condition. In response to the ointment approval, the team at Probiotic Action offer rosacea patients a chemical free rosacea treatment option to battle the bumps and pimples of rosacea outbreaks.

Rosacea, aside from the red blotchy flare ups, has been said to have similar links to acne. The tiny bumps, pustules, and breakouts associated with rosacea flare ups have been linked to bacteria similar to, if not identical to, what causes acne. While many rosacea patients may now find relief from facial redness, unless they battle the P.acnes bacteria causing breakouts, their relief from rosacea may not be complete. In order to battle rosacea breakouts without chemicals, Probiotic Action suggests a topical probiotic, and probiotic cleanser regimen. Using probiotic based treatments (once approved for use with topical redness relieving ointments) will allow users to treat their skin condition, without the fear of chemical reactions.

Fernando Perez, a spokesman for Probiotic Action shared his expertise on caring for rosacea, “Rosacea, is very similar to acne and eczema, and even psoriasis. All of these skin conditions are based on a chemical unbalance in the immune system, and are worsened by unbalanced levels on bacteria. Caring for the body system internally and externally through diet, by regularly visiting a physician, as well as taking supplements to balance body bacteria levels, may be an additional option to caring for numerous skin conditions”.

For more information on using probiotics for rosacea, eczema, and acne and other skin conditions, visit and like them on Facebook for reviews and product updates.

Probiotic Action is an advanced acne treatment that uses Probiotics for acne containing the “good bacteria” that is naturally found on healthy human skin. By using probiotics, Probiotic Action is an effective treatment that restores the normal bacteria content on skin, while battling what causes acne. Probiotic Action will successfully clear skin when used as an adult acne treatment while protecting skin against bad bacteria, free radicals, and pollutants*.

*These statements have not been evaluated by the Food and Drug Administration. Probiotic Action is not intended to diagnose, treat, cure or prevent any disease.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
2. Fifth Cycle of Probiotics & Microbiota Research Grant Announced
3. Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function
4. Probiotic-Enriched Instant Chai Latte and Teas to be Launched by Ganeden Biotech and Tipton Mills
5. International Probiotics Association Excited To Learn The FDA Has Decided To Issue A New, Revised NDI Draft Guidance
6. UAS Laboratories Presents about Probiotic Selection Criteria, at Scientific Conference
7. Enterologics Highlights Growing News on Probiotics on the Web
8. Micropharma Convenes Expert Roundtable on New Role for Probiotics in Cardiovascular Disease in time for National Cholesterol Education Month
9. ViThera Novel Approach Using Probiotics to Deliver Elafin Shows Promise as a Future Inflammatory Bowel Disease (IBD) Treatment
10. Could probiotics help HIV patients?
11. Probiotic Action Comments on Acne Statistics by WebMD
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a range ... place between the two entities said Poloz. Speaking ... Ottawa , he pointed to the country,s inflation ... federal government. "In ... "Both institutions have common economic goals, why not sit down ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: ... to provide their customers enhanced security to access ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
Breaking Biology News(10 mins):